[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories (CRL)

Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,328,249
  • Shares Outstanding, K 47,739
  • Annual Sales, $ 4,015 M
  • Annual Income, $ -144,340 K
  • EBIT $ 544 M
  • EBITDA $ 1,113 M
  • 60-Month Beta 1.38
  • Price/Sales 3.41
  • Price/Cash Flow 13.06
  • Price/Book 4.81

Options Overview Details

View History
  • Implied Volatility 44.62% (+1.15%)
  • Historical Volatility 45.93%
  • IV Percentile 34%
  • IV Rank 30.78%
  • IV High 71.52% on 02/17/26
  • IV Low 32.66% on 09/03/25
  • Expected Move (DTE 2) 3.57 (1.23%)
  • Put/Call Vol Ratio 0.05
  • Today's Volume 153
  • Volume Avg (30-Day) 292
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 7,262
  • Open Int (30-Day) 4,955
  • Expected Range 285.69 to 292.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $2.97
  • Number of Estimates 8
  • High Estimate $3.13
  • Low Estimate $2.92
  • Prior Year $2.43
  • Growth Rate Est. (year over year) +22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
213.40 +35.28%
on 07/21/26
294.45 -1.96%
on 08/19/26
+64.34 (+28.68%)
since 07/17/26
3-Month
147.51 +95.71%
on 05/20/26
294.45 -1.96%
on 08/19/26
+136.26 (+89.39%)
since 05/19/26
52-Week
144.26 +100.12%
on 09/25/25
294.45 -1.96%
on 08/19/26
+130.21 (+82.16%)
since 08/19/25

Most Recent Stories

More News
1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges

1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges

AEIS : 294.47 (-6.35%)
BJ : 93.92 (+1.33%)
CRL : 290.24 (+3.96%)
5 Insightful Analyst Questions From Charles River Laboratories’s Q2 Earnings Call

5 Insightful Analyst Questions From Charles River Laboratories’s Q2 Earnings Call

CRL : 290.24 (+3.96%)
Nasdaq Futures Slip as Western Digital and Sandisk Sink on Disappointing Guidance

September Nasdaq 100 E-Mini futures (NQU26) are down -0.42% this morning as concerns about the AI trade linger after forecasts from Western Digital and Sandisk fell short of investors’ lofty expectations....

APP : 310.72 (+1.13%)
SNDK : 1,563.26 (-3.85%)
CEG : 271.51 (+1.75%)
COP : 130.62 (+0.69%)
MNST : 47.67 (+0.61%)
NQU26 : 29,555.25 (-0.10%)
DDOG : 233.37 (-5.13%)
MU : 930.95 (-1.04%)
SIE.D.DX : 277.150 (+0.64%)
SOUN : 7.12 (+1.86%)
SPCX : 139.61 (-2.60%)
DTE.D.DX : 29.195 (+1.14%)
CRL Q2 Deep Dive: Strategic Portfolio Moves and Biopharma Demand Fuel Margin Expansion

CRL Q2 Deep Dive: Strategic Portfolio Moves and Biopharma Demand Fuel Margin Expansion

CRL : 290.24 (+3.96%)
Stock Indices Fall from Early Highs and Settle Mixed

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.17%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.83%. September...

AMAT : 493.14 (-4.12%)
B : 44.56 (+5.87%)
ANET : 188.11 (-2.62%)
HL : 20.03 (+11.59%)
CDE : 20.69 (+11.78%)
TXN : 271.19 (-0.39%)
$IUXX : 29,471.66 (-0.07%)
AMGN : 441.41 (+3.79%)
ZNU26 : 108-245 (+0.19%)
SHOP : 146.60 (+0.01%)
COMP : 12.68 (+3.09%)
ESU26 : 7,737.75 (+0.31%)
Stocks Supported by Stellar Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up +0.31%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.03%. September E-mini S&P futures...

AMAT : 493.14 (-4.12%)
B : 44.56 (+5.87%)
ANET : 188.11 (-2.62%)
HL : 20.03 (+11.59%)
CDE : 20.69 (+11.78%)
WYNN : 100.24 (-1.04%)
TXN : 271.19 (-0.39%)
$IUXX : 29,471.66 (-0.07%)
AMGN : 441.41 (+3.79%)
ZNU26 : 108-245 (+0.19%)
SHOP : 146.60 (+0.01%)
COMP : 12.68 (+3.09%)
Charles River Laboratories’s (NYSE:CRL) Q2 CY2026 Sales Top Estimates, Stock Soars

Charles River Laboratories’s (NYSE:CRL) Q2 CY2026 Sales Top Estimates, Stock Soars

CRL : 290.24 (+3.96%)
Charles River: Q2 Earnings Snapshot

Charles River: Q2 Earnings Snapshot

CRL : 290.24 (+3.96%)
Charles River Laboratories Announces Second-Quarter 2026 Results

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter ended June 27, 2026. Key Highlights ...

CRL : 290.24 (+3.96%)
Charles River Laboratories: When Even Lower Expectations Feel Optimistic

Barchart Research What to Expect from CRL Earnings CRL Generated August 4, 2026 Current Price $234.12 EPS Estimate $$2.72 Consensus Rating Moderate Buy Average Move 8.50% Charles River Laboratories: When...

CRL : 290.24 (+3.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 296.71
2nd Resistance Point 293.16
1st Resistance Point 286.17
Last Price 290.24
1st Support Level 275.63
2nd Support Level 272.08
3rd Support Level 265.09

See More

52-Week High 294.45
Last Price 290.24
Fibonacci 61.8% 237.08
Fibonacci 50% 219.36
Fibonacci 38.2% 201.63
52-Week Low 144.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.